USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Elobix AB

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Elobix ranks #26,218 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,218
of 49,997 US assignees by volume
31st percentile
by Innovation Score (29.5/100)
20.0
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26218 · Foreign Corporation #26,218 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,218/49,997
  • PHOTO-FINISH Elantas
  • CPC-NARROW C07D · 5 areas
  • INNOV-THIN 29.5/100
  • CLAIMS-DENSE 20.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Elantas GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Elobix’s 29.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Elobix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Elobix's Innovation Score is 29.5/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Elobix?

Each dot is one of Elobix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Elobix’s own 20.0 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Elobix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 510152025 Granted patents (volume) Avg claims / patent Elantas GMBH - 10, 14.1ElantasElantas PDG - 10, 19.2Elantas PDGElectric Power Development Co., Ltd. - 10, 8.2Electric Power De…Electro Terminal GMBH & Co KG - 10, 12.5Electro Terminal…Elpida Memory, Inc. - 10, 14.4Elpida MemoryEmbraco INDÚSTRIA DE Compressores E SOLUÇÕES EM REFRIGERAÇÃO Ltda. - 10, 12.1Embraco INDÚStria…EMPA - 10, 19.9EMPAEmpirico Inc. - 10, 17EmpiricoElobix AB - 10, 20Elobix AB
Elobix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Elobix's grants concentrate

Elobix AB is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2016. By volume, Elobix sits between Elantas GMBH and Empirico Inc..

Elobix's three-year grant acceleration

Elobix AB shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Elobix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Elobix holds 10 patents at rank #26,193, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Elobix

By rank, the assignees closest to #26,193 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Elobix's primary technology class.

Elobix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2016201720192020202120232025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Elobix AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 10.0%
2017 2 20.0%
2019 3 30.0%
2020 1 10.0%
2021 1 10.0%
2023 1 10.0%
2025partial year 1 10.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Elobix AB's patent record in context - here's where to go next.

  • Elobix AB's lead technology class is C07D (Heterocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #26,218 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Elobix AB against Elantas GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.